- Report
- August 2023
- 180 Pages
Global
From €3304EUR$3,750USD£2,866GBP
- Report
- August 2023
- 180 Pages
Global
From €3304EUR$3,750USD£2,866GBP
- Report
- July 2023
- 220 Pages
Global
€4049EUR$4,595USD£3,512GBP
- Report
- November 2022
- 150 Pages
Global
From €4273EUR$4,850USD£3,707GBP
From €3290EUR$4,000USD£2,954GBP
- Book
- January 2020
- 378 Pages
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 75 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
€6344EUR$7,200USD£5,503GBP
- Training
- 80 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more